| Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update |
18 |
| Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease |
8 |
| Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study |
6 |
| Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline |
6 |
| Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis |
6 |
| Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life |
5 |
| Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies |
5 |
| Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review |
5 |
| Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL Study |
5 |
| Evaluation and comparison of capsule endoscopy scores for assessment of inflammatory activity of small-bowel in Crohn's disease |
5 |
| Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update |
4 |
| Role of altered immune cells in liver diseases: a review |
4 |
| Metabolism of wheat proteins by intestinal microbes: Implications for wheat related disorders |
4 |
| Small intestinal bacterial overgrowth is common after gastrectomy but with little impact on nutritional status |
4 |
| Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation |
3 |
| Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients |
3 |
| Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin |
2 |
| Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey |
2 |
| Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in Spain |
2 |
| Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH) |
2 |
| Hospital Anxiety and Depression Scale (HADS): Validation in Mexican Patients with Inflammatory Bowel Disease |
2 |
| Retrospective analysis of the use of quadruple therapy with bismuth (Pylera (R)) in real-life clinical practice in Spin |
2 |
| Efficacy of tofacitinib treatment in ulcerative colitis |
2 |
| Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain |
2 |
| Gastric peroral endoscopic myotomy for gastroparesis: A systematic review of efficacy and safety |
2 |
| Update on the management of Helicobacter pylori infection. Position paper from the Catalan Society of Digestology |
2 |
| Short- and long-term clinical outcomes of self-expandable metal stents inserted for colorectal obstruction and efficacy of different insertion techniques |
2 |
| Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH) |
2 |
| Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology |
2 |
| Epistaxis in the cirrhotic patient: A complication to be considered |
2 |
| Comparison of non-invasive models for predicting liver damage in chronic hepatitis B patients |
2 |
| Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma |
1 |
| Strategies to optimise the quality of bowel cleansing |
1 |
| Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital |
1 |
| Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis? |
1 |
| Negative video capsule enteroscopy - what's the next step? |
1 |
| Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review |
1 |
| Evaluation and management of acute pancreatitis in Spain |
1 |
| Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease |
1 |
| Autologous haematopoietic stem cell transplantation in refractory Crohn's disease: Experience in our centre |
1 |
| Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding |
1 |
| Update on acute-on-chronic liver failure |
1 |
| Fluoroscopy-assisted vs fluoroless endoscopic ultrasound-guided transmural drainage of pancreatic fluid collections: A comparative study |
1 |
| Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years |
1 |
| Metronidazole in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection in high-risk hospitalised patients |
1 |
| VI consensus document by the Spanish Liver Transplantation Society |
1 |
| Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view |
1 |
| Clinical guidelines for endoscopic mucosal resection of non-pedunculated colorectal lesions |
1 |
| Reviewing the therapeutic role of budesonide in Crohn's disease |
1 |
| The effects of hepatic steatosis on thromboxane A(2) induced portal hypertension |
1 |
